Literature DB >> 10565625

Peeling agents: toxicological and allergological aspects.

N Cassano1, G Alessandrini, M Mastrolonardo, G A Vena.   

Abstract

BACKGROUND: The use of peeling agents is very common in clinical practice. However, despite the overall good safety profile, it is not without any inherent risk; therefore, clinicians should be adequately informed about potential risk in order to avoid or prevent them.
OBJECTIVE: This paper reviews toxicological and allergological aspects of peeling agents in general, also beyond their actual use in peeling procedures. Toxic and allergic reactions from peeling agents are rather uncommon and have been rarely reported in association with the medical use of peels.
METHODS: Systemic toxic effects may essentially derive from phenol and potentially from two phenol derivatives, resorcinol and salicylic acid. A complete understanding of the toxicological profile of peeling agents, along with a correct execution of the technique and a carefully selection of patients, can help avoid serious side effects.
RESULTS: Allergic contact reactions occur most frequently with resorcinol, while most peeling agents are only rare sensitizers or appear to be free of true sensitizing power. Other types of hypersensitivity response seem to be very rare.

Entities:  

Mesh:

Year:  1999        PMID: 10565625

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  3 in total

1.  The Efficacy and Safety of 4-n-butylresorcinol 0.1% Cream for the Treatment of Melasma: A Randomized Controlled Split-face Trial.

Authors:  Sun Young Huh; Jung-Won Shin; Jung-Im Na; Chang-Hun Huh; Sang-Woong Youn; Kyoung-Chan Park
Journal:  Ann Dermatol       Date:  2010-02-28       Impact factor: 1.444

Review 2.  Facial rejuvenation for middle-aged women: a combined approach with minimally invasive procedures.

Authors:  Alberto Goldman; Uwe Wollina
Journal:  Clin Interv Aging       Date:  2010-09-23       Impact factor: 4.458

Review 3.  [Topical and novel device-based therapies for mild hidradenitis suppurativa].

Authors:  G Nikolakis; E von Stebut
Journal:  Hautarzt       Date:  2021-07-05       Impact factor: 0.751

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.